Formulation and evaluation of ocular drops containing solid dispersion of tobramycin

Formulation and Evaluation of Solid Dispersion of Atorvastatin Calcium

The present study was designed to improve the solubility and hence enhance the dissolution of hydrophobic drug Atorvastatin calcium (ATC) in order to increase its bioavailability. Solid dispersion of atorvastatin calcium using carrier PEG 4000 was formulated in different ratios by conventional fusion and microwave induced fusion method. In particular, the Microwave technology has been considere...

Formulation and Evaluation of Solid Dispersion of Olanzepine

Formulation and Evaluation of Solid Dispersion of Olanzepine

The poor dissolution rate of water-insoluble drugs is still a major problem conforming the pharmaceutical industry. The most common method for improving the solubility is by increasing the surface area of the drug through micronization. But, in practice the effect of micronization is often disappointing, especially when the drugs are encapsulated or tablet. It is generally recognized that low s...

Formulation and evaluation of Moxifloxacin hydrochloride ocular nanoparticles

The objective of the present study was to prepare controlled release formulation of Moxifloxacin hydrochloride ocular nanoparticles. The nanoparticles were prepared by solvent displacement method using Eudragit RL 100 as a polymer. Different formulations were prepared by varying the ratios of drug and polymer and varying the ratios of organic and aqueous phase. The formulations were evaluated i...

Formulation and evaluation of Moxifloxacin hydrochloride ocular nanoparticles

The objective of the present study was to prepare controlled release formulation of Moxifloxacin hydrochloride ocular nanoparticles. The nanoparticles were prepared by solvent displacement method using Eudragit RL 100 as a polymer. Different formulations were prepared by varying the ratios of drug and polymer and varying the ratios of organic and aqueous phase. The formulations were evaluated i...